Abstract:Objective: This study aims to evaluate human papillomavirus (HPV) viral loads as a biomarker for triage into colposcopy and cervical intraepithelial neoplasia grade 2 (CIN2) therapy to reduce the colposcopy referral rate and CIN2 overtreatment in low-resource settings.Methods: In 1999, 1997 women aged 35 to 45 years in Shanxi, China, received 6 cervical screenings with pathological confirmation. In 2005, 1461 histologically normal women, 99 with CIN grade 1 (CIN1), and 30 with CIN2 or worse (CIN2+) were rescreened in a follow-up study. Human papillomavirus was detected by Hybrid Capture 2. Viral load, estimated by the ratio of relative light units to standard positive control (RLU/PC), was categorized into 4 groups: negative (<1.0), low (>= 1.0, <10.0), moderate (>= 10.0, <100.0), and high (>= 100.0). We estimated the cumulative incidence of CIN2+ by viral load subgroups and calculated adjusted hazard ratios for CIN2+ using Cox proportional hazards regression.Results: Cumulative incidence of CIN2+ increased with baseline HPV viral loads among normal women and women with CIN1 at baseline (P-trend < 0.001). Repeat moderate-high viral load was associated with the highest risk for CIN2+ (adjusted hazard ratio, 188.8; 95% confidence interval, 41.2-864.1). Raising the ratio of relative light units to standard positive control cutoff from 1.0 to 10.0 for colposcopy greatly reduced the referral rate from 18.1% to 12.9%. It also increased the specificity (84.8% vs 90.4%), the positive predictive value (22.5% vs 28.9%), and the positive likelihood ratio (6.4 vs 8.9), yet with loss of sensitivity by 12% (97.6% vs 85.7%). Among women with CIN2 at baseline, 56% regressed to normal, 24% regressed to CIN1, 4% remained CIN2, and 16% progressed to CIN grade 3 or worse.Conclusions: Locales using HPV testing as the primary screening method and lacking high-quality cytology-based screening should consider viral load as an alternative to colposcopy triage for women older than 35 years. Viral loads may also predict CIN2 progression until additional biomarkers become available.

Correlation of different HPV genotype viral loads and cervical lesions: A retrospective analysis of 1585 cases

The correlation of high-risk type human papillomavirus load with cervical carcinoma and precancerous lesions

The association between human papillomavirus (HPV) 16, HPV18, and other HR-HPV viral load and the histological classification of cervical lesions: Results from a large-scale cross-sectional study.

Prevalence of High-Risk Human Papillomavirus and Cervical Lesion Risk Factors: A Population-Based Study in Zhejiang, China 2010-2019

HR-HPV viral load quality detection provide more accurate prediction for residual lesions after treatment: a prospective cohort study in patients with high-grade squamous lesions or worse

Diagnostic value of high‐risk human papillomavirus viral load on cervical lesion assessment and ASCUS triage

Evaluation of Viral Load As a Triage Strategy with Primary High-Risk Human Papillomavirus Cervical Cancer Screening.

Distribution of cervical lesions in high-risk HPV (hr-HPV) positive women with ASC-US: a retrospective single-center study in China

The study of correlation between viral load of high risk human papillomavirus and cervical cancer and precancer

The relationship between the human papillomavirus viral load and the degree of pathology in the cervical intraepithelial neoplasia

Study on correlation between cervical precancerous lesion and HPV types and viral load

Correlation between high-risk HPV subtypes infection and cervical cancer/high-grade cervical lesions

Six-Year Regression and Progression of Cervical Lesions of Different Human Papillomavirus Viral Loads in Varied Histological Diagnoses

Correlation between persistent infection of high-risk HPV and precancerous cervical lesions

Type-Specific Viral Load and Physical State of HPV Type 16, 18, and 58 as Diagnostic Biomarkers for High-Grade Squamous Intraepithelial Lesions or Cervical Cancer

Comparison of HPV Genotypes and Viral Load Between Different Sites of Genital Tract: the Significance for Cervical Cancer Screening.

The risk of cervical lesions caused by HPV16/18 combined with other high-risk and low-risk HPV types: A retrospective study

Human Papillomavirus Genotype Prevalence in the Women of Shanghai, China and Its Association with the Severity of Cervical Neoplasia.

Correlation of Cervical Lesions and Cervical High-risk HPV Infection in 553 Women

Risk of cervical lesions in high-risk HPV positive women with normal cytology: a retrospective single-center study in China

The study into the loads of HPV and infection of HPV with a virus incervical carcinom and cervical intraepithelial neplasia